Authors Larribere L, Wu H, Novak D, Galach M, Bernhardt M, Orouji E, Weina K, Knappe N, Sachpekidis C, Umansky L, Beckhove P, Umansky V, De Schepper S, Kaufmann D, Ballotti R, Bertolotto C, Utikal J
Pigment cell & melanoma research Jul 2015
Is it time to test biguanide metformin in the treatment of melanoma?Authors Cerezo M, Tomic T, Ballotti R, Rocchi S
Pigment cell & melanoma research Jun 2014
Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.Authors Fernández-Barral A, Orgaz JL, Baquero P, Ali Z, Moreno A, Tiana M, Gómez V, Riveiro-Falkenbach E, Cañadas C, Zazo S, Bertolotto C, Davidson I, Rodríguez-Peralto JL, Palmero I, Rojo F, Jensen LD, del Peso L, Jiménez B
Neoplasia (New York, N.Y.) Jun 2014
A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib.Authors Allegra M, Giacchero D, Segalen C, Dumaz N, Butori C, Hofman V, Hofman P, Lacour JP, Bertolotto C, Bahadoran P, Ballotti R
The Journal of investigative dermatology May 2014
A germline oncogenic MITF mutation and tumor susceptibility.Authors Paillerets BB, Lesueur F, Bertolotto C
European journal of cell biology Feb Jan
Metabolism under the spotlight in senescence.Authors Bertolotto C
Pigment cell & melanoma research Jan 2014
Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy.Authors Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, Burton EA, Bollag G, Ballotti R, Bastian BC
Pigment cell & melanoma research Aug 2013
Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner.Authors Cerezo M, Tichet M, Abbe P, Ohanna M, Lehraiki A, Rouaud F, Allegra M, Giacchero D, Bahadoran P, Bertolotto C, Tartare-Deckert S, Ballotti R, Rocchi S
Molecular cancer therapeutics Jun 2013
Melanoma: from melanocyte to genetic alterations and clinical options.Authors Bertolotto C
Scientifica Jan 2013
Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells.Authors Bonet C, Giuliano S, Ohanna M, Bille K, Allegra M, Lacour JP, Bahadoran P, Rocchi S, Ballotti R, Bertolotto C
The Journal of biological chemistry Jul 2012